Recent advances in research on the mechanisms and treatment of LncRNAs in lymphoma

Long non-coding RNA (lncRNA) refers to RNA molecules exceeding 200 nucleotides in length that possess minimal protein-coding potential. These molecules play a crucial regulatory role in the initiation and progression of tumors.Lymphoma poses a significant global health burden, with substantial incidence and mortality worldwide. Although current treatment methods have demonstrated good efficacy, many cases still experience recurrence. Therefore, further in-depth exploration of its mechanism and the development of more effective targeted drugs are still necessary. In this paper, we review the fundamental principles of lncRNAs in lymphoma, outline the mechanisms by which lncRNAs influence lymphoma—including their role in regulating novel tumor cell death pathways such as ferroptosis, cuproptosis, and pyroptosis—and discuss their potential clinical applications in lymphoma. Overall, this review presents a novel approach for LncRNA-targeted therapy in lymphoma.

Authors

Institutions

Publication Details

Journal
Discover Oncology
Published
2026-11-17
DOI
https://doi.org/10.1007/s12672-026-06311-3
Primary Topic
Cancer-related molecular mechanisms research
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Recent advances in research on the mechanisms and treatment of LncRNAs in lymphoma

Lanlan Zang, Qingjun Meng, Jinlian Hu, Ruonan Li et al.
1 links
Discover Oncology
Cancer-related molecular mechanisms research
article

Recent advances in research on the mechanisms and treatment of LncRNAs in lymphoma

Lanlan Zang, Qingjun Meng, Jinlian Hu, Ruonan Li, Hongye Ren, Cailing Hao, Yanan Zhao, Haiquan Wang, Guifen Wang, Yu Zhang
article en

Abstract

Long non-coding RNA (lncRNA) refers to RNA molecules exceeding 200 nucleotides in length that possess minimal protein-coding potential. These molecules play a crucial regulatory role in the initiation and progression of tumors.Lymphoma poses a significant global health burden, with substantial incidence and mortality worldwide. Although current treatment methods have demonstrated good efficacy, many cases still experience recurrence. Therefore, further in-depth exploration of its mechanism and the development of more effective targeted drugs are still necessary. In this paper, we review the fundamental principles of lncRNAs in lymphoma, outline the mechanisms by which lncRNAs influence lymphoma—including their role in regulating novel tumor cell death pathways such as ferroptosis, cuproptosis, and pyroptosis—and discuss their potential clinical applications in lymphoma. Overall, this review presents a novel approach for LncRNA-targeted therapy in lymphoma.

Discover Oncology
Linyi People's Hospital (CN), Qilu Medical University (CN)
Natural Science Foundation of Shandong Province
Good health and well-being
Cancer-related molecular mechanisms research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon